Stefan Huttenlocher
SAPHIR Radiochirurgie, University Hospital Schleswig-Holstein
Papers
7
Total Citations
165
H-Index
6
About
Stefan Huttenlocher is a radiation oncologist whose research has made significant contributions to the field of stereotactic body radiation therapy (SBRT), with a particular focus on robotic-guided treatment systems and motion compensation technologies. His work centers on optimizing SBRT for liver metastases, lung tumors, and localized prostate cancer, consistently exploring how precision delivery techniques can improve clinical outcomes while minimizing toxicity. Among his most influential contributions is his development and clinical validation of gross tumor volume (GTV) mean-dose-optimized robotic SBRT, demonstrated across both liver and lung tumor cohorts treating hundreds of patients — work that has collectively garnered over 60 citations. His investigations into breathing-motion-compensated robotic guidance and the dosimetric implications of residual tracking errors have helped establish rigorous standards for real-time motion management in SBRT practice. His direct dose-correlation studies of MRI-detected liver tissue changes after SBRT further reflect his commitment to understanding treatment-related tissue response. Huttenlocher also played a leading role in the prospective German HYPOSTAT trial, the first German multicenter phase II study of hypofractionated robotic SBRT for localized prostate cancer, representing a meaningful step toward establishing evidence-based hypofractionation protocols. His body of work positions him as a key figure in advancing precision radiotherapy toward safer, more effective clinical application.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7